The Impact of Highly Effective Modulator Therapy on Cystic Fibrosis Microbiology and Inflammation

Caverly, L. J., Riquelme, S. A., & Hisert, K. B. (2022). The Impact of Highly Effective Modulator Therapy on Cystic Fibrosis Microbiology and Inflammation. Clinics in Chest Medicine, 43(4), 647–665. https://doi.org/10.1016/j.ccm.2022.06.007
Authors:
Lindsay J Caverly
Sebastián A Riquelme
Katherine B Hisert
Affiliated Authors:
Sebastián A Riquelme
Columbia Affiliation:
Subjects:
Cystic Fibrosis (MeSH)
Quinolones (MeSH)
Author Keywords:
inflammation
infection
cystic fibrosis transmembrane regulator
modulator
highly effective cystic fibrosis transmembrane conductance regulator modulator therapy (hemt)
cystic fibrosis
elink
Publication Type:
Article
Unique ID:
10.1016/j.ccm.2022.06.007
PMID:
36344072
DOI:
10.1016/j.ccm.2022.06.007
Journal:
Clinics in Chest Medicine
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Web of Science Record

Record Created: